Status:
RECRUITING
European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries
Lead Sponsor:
University of Padova
Collaborating Sponsors:
IRCCS Policlinico S. Donato
Mitera Children's Hospital, Athens Heart Surgery Institute, Greece
Conditions:
Congenital Heart Disease
Coronary Artery Anomaly
Eligibility:
All Genders
Brief Summary
Anomalous aortic origin of a coronary artery (AAOCA) is a group of rare congenital heart defects with various clinical presentations. The lifetime-risk of an individual living with AAOCA is unknown, a...
Detailed Description
EURO AAOCA study database on management for "ANOMALOUS AORTIC ORIGIN OF CORONARY ARTERIES. This is a simple Excel database in 8 sections (see below). The patient's identification (ID) should be anony...
Eligibility Criteria
Inclusion
- All patients with a diagnosis of AAOCA (either referred to surgery or to medical follow-up )
Exclusion
- isolated high-coronary take-off (≥ 5mm above sino-tubular junction), anomalous origin of a circumflex from the right coronary artery, anomalous course with a normal origin, and association to major congenital heart disease (i.e. Tetralogy of Fallot, transposition of the great arteries, anomalous origin of a coronary from the pulmonary artery).
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06089902
Start Date
January 1 2019
End Date
January 1 2029
Last Update
October 19 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Massimo Padalino
Padua, PD, Italy, 35128
2
Christopher Grani
Bern, Switzerland